These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30963672)

  • 61. Stem/Progenitor Cells and Pulmonary Arterial Hypertension.
    Pu X; Du L; Hu Y; Fan Y; Xu Q
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):167-178. PubMed ID: 33028095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
    Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
    Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
    Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
    Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
    Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
    Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.
    Pereira TA; Syn WK; Machado MV; Vidigal PV; Resende V; Voieta I; Xie G; Otoni A; Souza MM; Santos ET; Chan IS; Trindade GV; Choi SS; Witek RP; Pereira FE; Secor WE; Andrade ZA; Lambertucci JR; Diehl AM
    Clin Sci (Lond); 2015 Nov; 129(10):875-83. PubMed ID: 26201095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.
    Ruffenach G; Chabot S; Tanguay VF; Courboulin A; Boucherat O; Potus F; Meloche J; Pflieger A; Breuils-Bonnet S; Nadeau V; Paradis R; Tremblay E; Girerd B; Hautefort A; Montani D; Fadel E; Dorfmuller P; Humbert M; Perros F; Paulin R; Provencher S; Bonnet S
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1273-1285. PubMed ID: 27149112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current status of pulmonary arterial hypertension in Korea.
    Jang AY; Chung WJ
    Korean J Intern Med; 2019 Jul; 34(4):696-707. PubMed ID: 31272141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.
    Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK
    Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension.
    Rafikov R; Nair V; Sinari S; Babu H; Sullivan JC; Yuan JX; Desai AA; Rafikova O
    Antioxid Redox Signal; 2019 Nov; 31(13):917-932. PubMed ID: 30652485
    [No Abstract]   [Full Text] [Related]  

  • 78. Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs).
    Bellan M; Piccinino C; Tonello S; Minisini R; Giubertoni A; Sola D; Pedrazzoli R; Gagliardi I; Zecca E; Calzaducca E; Mazzoleni F; Piffero R; Patti G; Pirisi M; Sainaghi PP
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33919476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.
    McDowell RE; Aulak KS; Almoushref A; Melillo CA; Brauer BE; Newman JE; Tonelli AR; Dweik RA
    Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L562-L569. PubMed ID: 32022593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.